InterSystems Takes Healthcare IT Leadership Position in France

InterSystemsInterSystems Corporation today announced the strategic acquisition of Siemens Health Services (SHS) France from its Siemens parent company. SHS, a long-term leader in the delivery of healthcare solutions to hospitals in France, will now operate as "InterSystems SAS". This acquisition moves InterSystems into a strong position in France, which is one of the world’s top five healthcare IT markets by revenue, and marks the entry of InterSystems TrakCare™ advanced clinical applications into this market.

Paul Grabscheid, InterSystems Vice President for Strategic Planning said, "SHS is well respected for its proven Clinicom™ administration and billing system for hospitals. The 60+ hospitals running Clinicom include some of the most advanced users of healthcare IT in the country. This initiative brings to France InterSystems' global healthcare experience and proven TrakCare software, which complements and extends the capabilities of Clinicom."

TrakCare is employed by leading institutions in 25 countries, with implementations that range from single hospitals to region wide, fully integrated healthcare networks serving millions of patients. In France, Clinicom and TrakCare will be combined to form a complete administrative and clinical system that is optimised for French care delivery policies and practices. This combination is facilitated by the facts that both products run on InterSystems Caché® database technology and that the two organisations have worked together as partners for more than a decade.

"This acquisition significantly expands the choices available to our customers," Grabscheid continued. "They will continue to benefit from the investments they have made in Clinicom, which we will continue to enhance and support; they can take advantage of the breakthrough clinical capabilities in TrakCare to enhance the safety, effectiveness and efficiency of the care they provide for patients; and they can utilise the connected healthcare technologies of InterSystems HealthShare™ to link systems and people within their organisation or across a community or region."

InterSystems SAS will focus on hospitals in the public sector, which accounts for 62% of the overall French hospital market. The SHS private healthcare business will be sold to WEB100T, a Merignac, France-based company with a strong track record in this sector. The sale to Web100T is expected to close in several months, following the completion of the required legal processes.

InterSystems is the global leader in breakthrough solutions for connected care, with major electronic health record projects under way in multiple countries including Sweden, Scotland, England, Chile, Brazil and United States.

Related news articles:

About InterSystems
InterSystems Corporation is a global software leader with headquarters in Cambridge, Massachusetts, and offices in 23 countries. InterSystems provides advanced technologies for breakthrough applications. InterSystems TrakCare™ is a Web-based healthcare information system that rapidly delivers the benefits of an Electronic Patient Record (TrakCare is not available in the United States.) InterSystems Ensemble® is a seamless platform for integration and the development of connectable applications. InterSystems Caché ® is a high performance object database that makes applications faster and more scalable. InterSystems HealthShare™ is a strategic platform for healthcare informatics and the creation of an Electronic Health Record on a regional or national scale. InterSystems DeepSee™ is software that makes it possible to embed real-time business intelligence capabilities in transactional applications. For more information, visit InterSystems.com.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...